BCL2 and nephritis: Patients with jSLE without nephritis had significantly reduced proportion of Bcl-2–expressing NK cells [median: 70.7% (range: 5.0–95.8) vs. median: 94.8% (range: 87.6–100.0), p = 0.04] when compared to healthy controls.